In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

AHP, Hyseq develop gene products

Executive Summary

Pharmacogenomics and DNA analysis biopharmaceutical company Hyseq has entered into a 3.5 year deal with American Home Products' agricultural products division American Cyanamid to discover genes and develop gene products. Hyseq gets $60mm over the term of the deal, and royalties on resulting products sold by AC.
Deal Industry
  • Pharmaceuticals
    • Nutraceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
Deal Status
  • Concluded
Deal Type
  • Alliance
    • Co-Promotion
    • Includes Contract
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register